Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy Laura Testa; Max Mano; Roberto Jun Arai; Renata Colombo Bonadio; Sergio V. Serrano; Marina M Costa Zorzetto; Susanne Crocamo; Oren Smaletz; Ruffo Freitas-Junior; Paulo M. Hoff;

Prognostic nomogram based on pre-treatment HALP score for patients with advanced non-small cell lung cancer Shan Gao; Qin Huang; Suosu Wei; Yanru Lv; Yanyan Xie; Yanrong Hao;

Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells Maria Fernanda Lopes Carvalho; Carolina Santana Calicchio; Bruna Oliveira de Almeida; Livia Bassani Lins de Miranda; Jean Carlos Lipreri da Silva; Keli Lima; João Agostinho Machado-Neto;